Imperva (IMPV) Reports Q4 EPS of $0.40
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Imperva (IMPV) PT Raised to $55 at Imperial Capital on 4Q; 'Strong Subscription Growth and Large Transactions'
February 9, 2018 1:11 PM ESTImperial Capital raised its price target on Imperva (NASDAQ: IMPV) to $55.00 (from $50.00) while maintaining a Outperform rating, following the company's fourth quarter earnings report.
Analyst Michael Kim notes a positive outlook on the shares, as the company reported fourth quarter earnings per share... More
